Navigation Links
SAP Appoints John Papandrea to Lead Healthcare Business Unit
Date:10/6/2008

WALLDORF, Germany, Oct. 6 /PRNewswire-FirstCall/ -- SAP AG (NYSE: SAP) today announced that John Papandrea has joined SAP as senior vice president of the Healthcare industry business unit. In this position, effective August 1, 2008, Mr. Papandrea will help drive SAP's industry leadership efforts in providing strategic software solutions to healthcare organizations around the world. The announcement was made in conjunction with the 3rd annual Ambassadors Dinner and the U.S.-EU eHealth Conference, both organized by the European-American Business Council in Brussels and Paris.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050310/SFTH009LOGO-a)

"With his immense business management experience, Mr. Papandrea will be a tremendous asset to SAP and to our customers in the healthcare industry," said Bob Stutz, head of Industries Solutions and corporate officer of SAP. "We consider healthcare as one of our most important growth markets in the years to come. I am in particular delighted that John brings his in-depth knowledge of the U.S. healthcare market -- the largest single healthcare market worldwide."

Bringing vast experience managing people and resources, as well as building business cases for information technology investments in healthcare, Mr. Papandrea joins SAP from Deloitte Consulting, where he advised large healthcare organizations on information technology strategy, effective use of technology and technology innovation.

Previously, John Papandrea worked with Capgemini and Ernst & Young, driving strategic partner relationships and advising clients on the value derived from the use of information technology in healthcare, particularly in the clinical arena.

John Papandrea holds a bachelor's degree in biomedical science from the University of Technology Sydney, and a master's degree in Health Administration from the University of New South Wales, both located in Sydney, Australia.

Photos of John Papandrea are available. Please contact one of the media contacts mentioned in this announcement.

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP's future financial results are discussed more fully in SAP's filings with the U.S. Securities and Exchange Commission ("SEC"), including SAP's most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.

Copyright (C) 2008 SAP AG. All rights reserved.

SAP, R/3, mySAP, mySAP.com, xApps, xApp, SAP NetWeaver and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP AG in Germany and in several other countries all over the world. All other product and service names mentioned are the trademarks of their respective companies. Data contained in this document serve informational purposes only. National product specifications may vary.

For customers interested in learning more about SAP products:

Global Customer Center: +49 180 534-34-24

United States Only: 1 (800) 872-1SAP (1-800-872-1727)

Contacts:

Evan Welsh, +49 (0)6227 7-67514, evan.welsh@sap.com, CET

Andy Kendzie, +1 (202) 312-3919, andy.kendzie@sap.com, EDT

Janina Buchholz, Burson-Marsteller

+1 (415) 591-4081, janina.buchholz@bm.com, PDT


'/>"/>
SOURCE SAP AG
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. Novo Nordisk Appoints New Leader of North American Business
3. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
4. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
5. Resonant Medical Appoints New Vice President of Global Sales
6. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
7. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
8. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
9. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
10. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
11. Adlyfe Appoints Roxanne Duan as Vice President of Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology: